As Rite Aid embarks on what its leaders have dubbed the company’s “Path to the Future,” among the assets executives said position it well for years to come is EnvisionRxOptions, its pharmacy benefits and services arm.
Fred’s also saw its net sales decrease 5.2% for the quarter, which ended May 4, coming in at $319 million, with comparable-store sales down 8.5% from the previous quarter.
Aspirin and extended-release dipyridamole capsules had a market value of roughly $158 million for the 12 months ended April 2019, according to IQVIA, although actual generic market values are expected to be lower.